Work

Abstract 4538: T-cell immunogenicity and biomarker profiling in advanced melanoma patients receiving the personalized vaccine EVX-01 in combination with pembrolizumab

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-4538

Authors: Mads Lausen, Michail A. Pavlidis, Rasmus Ohrt Andersen, Thomas Trolle, Nikolas Thuesen, Christian Garde, Nicholas Willumsen, Morten Asser Karsdal, Nadia Viborg, Adnan Khattak, Georgina V. Long, Paolo A. Ascierto, Carolina Cimminiello, Michael J. Chisamore, Stine Friis Thorsen, Birgitte Rønø, Daniela Kleine-Kohlbrecher

Institutions: Nordic Bioscience (Denmark), Melanoma Institute Australia, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409631487

Cites:

Cited by:

Related to: 10